Inpatient care burden due to cancers in Anhui, China: A cross-sectional household survey

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Zhao, Ting ^a   Cheng, Jing ^a   Chai, Jing ^a   Feng, Rui ^a   Liang, Han ^a   Shen, Xingrong ^a   Sha, Rui ^a   Wang, Debin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Costs; Financial burden; Household survey; Inpatient care

Indexed keywords

ADULT; AGED; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; FAMILY SIZE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRE; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADULT; AGED; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FAMILY CHARACTERISTICS; FEMALE; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RURAL POPULATION; SURVEYS AND QUESTIONNAIRES; URBAN POPULATION;

EID: 84963820881     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2995-z     Document Type: Article

References (33)

1. Guy Jr GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med. 2015;48(2):183-7. doi: 10.1016/j.amepre.2014.08.036. Epub 2014 Nov 10.
2. Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working-aged population. Am J Manag Care. 2009;15(11):801-6.
3. Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269-76. doi: 10.1200/JCO.2013.53.0956. Epub 2014 Mar 24.
4. Zaidi AA, Ansari TZ, Khan A. The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health. 2012;11:60. doi: 10.1186/1475-9276-11-60.
5. Hai-ping Z, Wan-qing C, Hai-ying Z, et al. The impact of cancer loss on family and regional economics. Chin Health Econ. 2013;32(11):65-6.
6. Dragomir A, Dinea D, Vanhuyse M, Cury FL, Aprikian AG. Drug costs in the management of metastatic castration-resistant prostate cancer in Canada. BMC Health Serv Res. 2014;14:252. doi: 10.1186/1472-6963-14-252.
7. Sakata S, Cronk M. The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia. Asia Pac J Clin Oncol. 2014;10(1):94-5. doi: 10.1111/ajco.12077. Epub 2013 May 29.
8. Regenbogen SE, Veenstra CM, Hawley ST, Banerjee M, Ward KC, Kato I, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014;120(19):3074-81. doi: 10.1002/cncr.28812. Epub 2014 May 29.
9. Färkkilä N, Torvinen S, Sintonen H, Saarto T, Järvinen H, Hänninen J, et al. Costs of colorectal cancer in different states of the disease. Acta Oncol. 2015;54(4):454-62. doi: 10.3109/0284186X.2014.985797. Epub 2014 Dec 18.
10. Nobrega CR, Lima AF. Procedures' costs related to outpatient chemotherapy treatment of women suffering from breast cancer. Rev Esc Enferm USP. 2014;48(4):698-705.
11. Mittmann N, Porter JM, Rangrej J, Seung SJ, Liu N, Saskin R, et al. Health system costs for stage-specific breast cancer: a population-based approach. Curr Oncol. 2014;21(6):281-93. doi: 10.3747/co.21.2143.
12. Xie Q, Wen F, Wei YQ, Deng HX, Li Q. Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer. Color Dis. 2013;15(8):958-62. doi: 10.1111/codi.12216.
13. Guy Jr GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749-57. doi: 10.1200/JCO.2013.49.1241. Epub 2013 Sep 16.
14. Lee KS, Chang HS, Lee SM, Park EC. Economic Burden of Cancer in Korea during 2000-2010. Cancer Res Treat. 2015;47(3):387-98. doi: 10.4143/crt.2014.001. Epub 2014 Nov 24.
15. Trogdon JG, Tangka FK, Ekwueme DU, Guy Jr GP, Nwaise I, Orenstein D. State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care. 2012;18(9):525-32.
16. de Oliveira C, Bremner KE, Pataky R, Gunraj N, Haq M, Chan K, Cheung WY, Hoch JS, Peacock S, Krahn MD. Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study. CMAJ Open. 2013;1(4):E151-8. doi: 10.9778/cmajo.20130041. eCollection 2013.
17. Liu LS, Shen LP, Jiang Y, Han ZF, Hong J. Effect of integrated Chinese medical treatment (as maintenance therapy) on the survival time of patients with advanced non-small-cell lung cancer: a clinical study. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014;34(5):526-30.
18. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145-50. doi: 10.1200/JOP.2014.001542. Epub 2014 Dec 16.
19. Zarogoulidou V, Panagopoulou E, Papakosta D, Petridis D, Porpodis K, Zarogoulidis K, et al. Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department. J Thorac Dis. 2015;7 Suppl 1:S12-9. doi: 10.3978/j.issn.2072-1439.2015.01.57.
20. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3 Suppl):46s-51s. doi: 10.1200/JOP.2011.000316.
21. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381-90. doi: 10.1634/theoncologist.2012-0279. Epub 2013 Feb 26.
22. Chino F, Peppercorn J, Taylor Jr DH, Lu Y, Samsa G, Abernethy AP, Zafar SY. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014;19(4):414-20. doi: 10.1634/theoncologist.2013-0374. Epub 2014 Mar 25.
23. Choi JW, Cho KH, Choi Y, Han KT, Kwon JA, Park EC. Changes in economic status of households associated with catastrophic health expenditures for cancer in South Korea. Asian Pac J Cancer Prev. 2014;15(6):2713-7.
24. Daneshkohan A, Karami M, Najafi F, Matin BK. Household catastrophic health expenditure. Iran J Public Health. 2011;40(1):94-9. Epub 2011 Mar 31.
25. Hao J, Chen W-q. Chinese cancer registry annual report 2012. Beijing: Press of Military Medical Sciences; 2012.
26. Pauly MV. Is high and growing spending on cancer treatment and prevention harmful to the United States economy? J Clin Oncol. 2007;25(2):171-4.
27. Lin Y, Ling L, Xu R-y. The relationship between changes in sex hormone level and physiology and disease of women in different age groups. Henan J Prev Med. 2010;21(3):179-81.
28. Warnakulasuriya S. Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent. 2009;10(1):4-5. doi: 10.1038/sj.ebd.6400623.
29. Xiaoqiang J, Xu R, Zheng J, Danhui Y, Qiuyan L, Yang H, et al. Influencing factor analysis on hospitalization costs of 3046 cases with colorectal cancer on basic medical insurance in Beijing. World Sci Technol. 2011;13(6):948-51.
30. Li-juan L, Yang W-x. Study on the First Visiting Medical Institutions and Influence Factors for Patients in Tianjin City. Chin Hosp Manage. 2011;31(2):12-3.
31. Cai-hong XU, Wei MA, Can-you Z, Hui Z, Li-xia W, Dong-mei W. Analysis on the reimbursement of medical expenses for multidrug resistant tuberculosis under three health insurance systems. Chin Prev Med. 2014;15(7):633-6.
32. de Oliveira C, Bremner KE, Pataky R, Gunraj N, Chan K, Peacock S, et al. Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study. CMAJ Open. 2013;1(1):E1-8. doi: 10.9778/cmajo.20120013. eCollection 2013.
33. Edwards B, Clarke V. The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients' illness characteristics on depression and anxiety. Psycho-Oncology. 2004;13(8):562-76.